206 related articles for article (PubMed ID: 29535799)
21. Metastasis suppressor NME1 in exosomes or liposomes conveys motility and migration inhibition in breast cancer model systems.
Khan I; Gril B; Hoshino A; Yang HH; Lee MP; Difilippantonio S; Lyden DC; Steeg PS
Clin Exp Metastasis; 2022 Oct; 39(5):815-831. PubMed ID: 35939247
[TBL] [Abstract][Full Text] [Related]
22. Characterization of Nme5-Like Gene/Protein from the Red Alga
Perina D; Korolija M; Mikoč A; Halasz M; Herak Bosnar M; Ćetković H
Mar Drugs; 2019 Dec; 18(1):. PubMed ID: 31877804
[TBL] [Abstract][Full Text] [Related]
23. Analysis of 1- and 3-Phosphohistidine (pHis) Protein Modification Using Model Enzymes Expressed in Bacteria.
Clubbs Coldron AKM; Byrne DP; Eyers PA
Methods Mol Biol; 2020; 2077():63-81. PubMed ID: 31707652
[TBL] [Abstract][Full Text] [Related]
24. Janus-faces of NME-oncoprotein interactions.
Vlatković N; Chang SH; Boyd MT
Naunyn Schmiedebergs Arch Pharmacol; 2015 Feb; 388(2):175-87. PubMed ID: 25366701
[TBL] [Abstract][Full Text] [Related]
25. Sponge non-metastatic Group I Nme gene/protein - structure and function is conserved from sponges to humans.
Perina D; Bosnar MH; Bago R; Mikoč A; Harcet M; Deželjin M; Cetković H
BMC Evol Biol; 2011 Apr; 11():87. PubMed ID: 21457554
[TBL] [Abstract][Full Text] [Related]
26. Mix and match of the tumor metastasis suppressor Nm23 protein isoforms in vitro and in vivo.
Potel CM; Fasci D; Heck AJR
FEBS J; 2018 Aug; 285(15):2856-2868. PubMed ID: 29863788
[TBL] [Abstract][Full Text] [Related]
27. Translational approaches using metastasis suppressor genes.
Palmieri D; Horak CE; Lee JH; Halverson DO; Steeg PS
J Bioenerg Biomembr; 2006 Aug; 38(3-4):151-61. PubMed ID: 16944301
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of action of NME metastasis suppressors - a family affair.
Prunier C; Chavrier P; Boissan M
Cancer Metastasis Rev; 2023 Dec; 42(4):1155-1167. PubMed ID: 37353690
[TBL] [Abstract][Full Text] [Related]
29. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
[TBL] [Abstract][Full Text] [Related]
30. Dynamin controls extracellular level of Awd/Nme1 metastasis suppressor protein.
Romani P; Papi A; Ignesti M; Soccolini G; Hsu T; Gargiulo G; Spisni E; Cavaliere V
Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1171-1182. PubMed ID: 27449069
[TBL] [Abstract][Full Text] [Related]
31. MDM2 interacts with NME2 (non-metastatic cells 2, protein) and suppresses the ability of NME2 to negatively regulate cell motility.
Polanski R; Maguire M; Nield PC; Jenkins RE; Park BK; Krawczynska K; Devling T; Ray-Sinha A; Rubbi CP; Vlatkovic N; Boyd MT
Carcinogenesis; 2011 Aug; 32(8):1133-42. PubMed ID: 21504894
[TBL] [Abstract][Full Text] [Related]
32. The metastasis suppressor Nm23 as a modulator of Ras/ERK signaling.
Takács-Vellai K
J Mol Signal; 2014; 9():4. PubMed ID: 24829611
[TBL] [Abstract][Full Text] [Related]
33. Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma.
Almgren MA; Henriksson KC; Fujimoto J; Chang CL
Mol Cancer Res; 2004 Jul; 2(7):387-94. PubMed ID: 15280446
[TBL] [Abstract][Full Text] [Related]
34. Metastasis Suppressor NME1 Directly Activates Transcription of the
Pamidimukkala NV; Leonard MK; Snyder D; McCorkle JR; Kaetzel DM
Anticancer Res; 2018 Nov; 38(11):6059-6068. PubMed ID: 30396920
[TBL] [Abstract][Full Text] [Related]
35. Nuclear functions of NME proteins.
Puts GS; Leonard MK; Pamidimukkala NV; Snyder DE; Kaetzel DM
Lab Invest; 2018 Feb; 98(2):211-218. PubMed ID: 29058704
[TBL] [Abstract][Full Text] [Related]
36. Structural comparison of highly similar nucleoside-diphosphate kinases: Molecular explanation of distinct membrane-binding behavior.
Francois-Moutal L; Marcillat O; Granjon T
Biochimie; 2014 Oct; 105():110-8. PubMed ID: 25010650
[TBL] [Abstract][Full Text] [Related]
37. Nm23 and tumour metastasis: basic and translational advances.
Freije JM; MacDonald NJ; Steeg PS
Biochem Soc Symp; 1998; 63():261-71. PubMed ID: 9513729
[TBL] [Abstract][Full Text] [Related]
38. [Immunohistochemical analysis of nm23 gene product/nucleoside-diphosphate kinase expression in human lung carcinoma].
Jiang Y; He A; Xia S
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Aug; 18(4):209-11, 254. PubMed ID: 8697510
[TBL] [Abstract][Full Text] [Related]
39. Proteomic analysis of NME1/NDPK A null mouse liver: evidence for a post-translational regulation of annexin IV and EF-1Bα.
Bruneel A; Wendum D; Labas V; Mulner-Lorillon O; Vinh J; Bosselut N; Ballot E; Baudin B; Housset C; Dabernat S; Lacombe ML; Boissan M
Naunyn Schmiedebergs Arch Pharmacol; 2011 Oct; 384(4-5):407-19. PubMed ID: 21541759
[TBL] [Abstract][Full Text] [Related]
40. A nucleoside diphosphate kinase A (nm23-H1) serine 120-->glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction.
Chang CL; Strahler JR; Thoraval DH; Qian MG; Hinderer R; Hanash SM
Oncogene; 1996 Feb; 12(3):659-67. PubMed ID: 8637723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
